Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Anupam Rasayan becomes world's first to make ETFA using flow chemistry
Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow chemistry technology. This advanced method offers enhanced safety and efficiency over traditional batch processes. ETFA is a vital component for pharmaceuticals and life sciences.
RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-September
RPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company also aims to enter the GLP-1 weight-loss therapy market by August-September. Despite geopolitical risks, RPG Life Sciences is strategically focusing on niche, complex molecules and expanding into new therapy areas.
Stock to buy: Jefferies lists 10 reasons to buy its top CRDMO pick Sai Life Sciences
Jefferies has initiated coverage on Sai Life Sciences with a 'Buy' rating and a Rs 1,300 target price, citing its integrated 'follow-the-molecule' model and strong growth outlook. The brokerage highlighted the company's healthy pipeline, global presence, and clean balance sheet as key investment drivers, projecting significant upside potential.
CCL Products, Sai Life Sciences on Mayuresh Joshi’s watchlist for earnings strength
Mayuresh Joshi, Director of Research at Marketsmith India, is watching earnings-resilient sectors such as consumer discretionary, banking, and pharmaceuticals as market remains volatile. Along with CCL Products and Sai Life Sciences, Strides Pharma Science and ICICI Bank are on his watchlist, while Vishal Mega Mart remains a domestic consumption play worth tracking.
Novo Holdings scales up India bets with bigger cheques, focus on mature healthcare assets
The life sciences investor is increasing ticket sizes and doubling down on speciality care and healthcare services as India emerges as a key deployment market in Asia.
Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing
Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and management roles. This move reflects a broader trend of global pharma companies expanding in India.
Telangana aims to make Hyderabad leading life sciences hub amid Centre’s Biopharma SHAKTI boost
Telangana is set to emerge as a major beneficiary of the Biopharma SHAKTI scheme, led by its well-established industry clusters, robust research ecosystem, and strong manufacturing capabilities. It already houses leading global pharmaceutical companies, such as Amgen, Zoetis, Evernorth, HCA Healthcare, Eli Lilly and Sanofi.
Taking Stock: Market recovers but Nifty ends below 24,000; Sensex falls 583 pts
More than 100 stocks touched their 52-week high on the BSE, including Himadri Speciality, HFCL, Sai Life Sciences, Coal India, Hitachi Energy, Navin Fluorine, ONGC, Apar Industries, MCX India, Lloyds Metals, Chennai Petro, among others.